Tocilizumab is a humanized anti-interleukin-6 receptor antibody for treating rheumatoid arthritis. Pharmacokinetic/pharmacodynamic analysis was performed on the 24-week double-blind parts of 2 randomized, controlled trials: SUMMACTA and BREVACTA. SUMMACTA compared subcutaneous tocilizumab 162 mg every week to intravenous tocilizumab 8 mg/kg every 4 weeks, whereas BREVACTA evaluated 162 mg subcu...

anticoagulation drugs are frequently used to prevent deep vein thrombosis in high-risk patients. subcutaneous low molecular weight heparin (lmwh) is increasingly used in both hospitalized patients and outpatient settings. this necessitates familiarity of both health care providers and patients with such treatment and vigilance on possible complications. here we present a case of hematoma of rec...